Suppr超能文献

乳酸脱氢酶-白蛋白比值对急性肾损伤危重症患者预后的影响。

Prognostic implication of lactic dehydrogenase-to-albumin ratio in critically ill patients with acute kidney injury.

机构信息

Department of Nephrology, Chengdu Second People's Hospital, Chengdu, China.

North Sichuan Medical College, Nanchong, China.

出版信息

Clin Exp Nephrol. 2023 Apr;27(4):349-357. doi: 10.1007/s10157-023-02321-5. Epub 2023 Jan 31.

Abstract

BACKGROUND

No studies have been published on the correlation between lactic dehydrogenase-to-albumin ratio (LAR) and poor prognosis of acute kidney injury (AKI) patients, warranting further research. This analysis sought to investigate the prognostic implication of LAR in critically ill patients with AKI.

METHODS

The present study enrolled 11,046 and 5180 adults with AKI from the Medical Information Mart for Intensive Care III (MIMIC III) and MIMIC IV, respectively. Data from MIMIC IV were identified as the training cohort, and those from MIMIC III were identified as the validation cohort. We applied multivariate regression analysis to identify the link between LAR and all-cause mortality. Restricted cubic spline (RCS) was conducted to figure out the correlation between LAR and in-hospital mortality. Furthermore, we carried out stratification analyses to examine if the effects of LAR on in-hospital mortality were consistent across various subclasses.

RESULTS

The level of LAR was remarkably higher in the in-hospital non-survivor group (p < 0.001). Furthermore, the increased LAR group presented a remarkably higher rate of in-hospital mortality at AKI stages 1, 2, and 3 compared with the decreased LAR group (all p < 0.001). Multivariate regression analyses exhibited the independent prognostic significance of LAR for all-cause mortality (all p < 0.001). MIMIC III observed concordant results. RCS indicated a non-linear correlation between LAR and in-hospital death (P for non-linearity < 0.001). The relationship between LAR and in-hospital mortality was still significant in patients with various subclasses.

CONCLUSIONS

Elevated LAR at admission is a prognostic risk factor for critically ill patients with AKI.

摘要

背景

目前尚未有研究报道乳酸脱氢酶与白蛋白比值(LAR)与急性肾损伤(AKI)患者不良预后之间的相关性,因此需要进一步研究。本分析旨在探讨 LAR 对重症 AKI 患者预后的影响。

方法

本研究纳入了分别来自 MIMIC III(11046 例成人)和 MIMIC IV(5180 例成人)的 AKI 患者。MIMIC IV 中的数据被确定为训练队列,MIMIC III 中的数据被确定为验证队列。我们应用多变量回归分析来确定 LAR 与全因死亡率之间的联系。限制性三次样条(RCS)用于确定 LAR 与住院死亡率之间的相关性。此外,我们进行了分层分析,以检查 LAR 对住院死亡率的影响是否在各个亚组中一致。

结果

住院期间非幸存者组的 LAR 水平显著升高(p<0.001)。此外,与 LAR 降低组相比,LAR 升高组在 AKI 1 期、2 期和 3 期的住院死亡率显著更高(均 p<0.001)。多变量回归分析显示 LAR 对全因死亡率具有独立的预后意义(均 p<0.001)。MIMIC III 也观察到了一致的结果。RCS 表明 LAR 与住院死亡之间存在非线性关系(P 非线性<0.001)。在具有各种亚类的患者中,LAR 与住院死亡率之间的关系仍然显著。

结论

入院时升高的 LAR 是重症 AKI 患者的预后危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c3/9887249/4d83f36bde61/10157_2023_2321_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验